B
Bioelectronica
Biotech & Life Sciences · Reno, United States · Founded 2017
A research-stage biotechnology company building next-generation digital tools for drug discovery, diagnostics, and cell sorting MoreLess
Bioelectronica is a research-stage biotechnology company focused on developing intelligent digital tools for drug discovery, cell screening, and cell sorting. Founded by Roger Chen and Jonathan Hull, the company leverages advanced technologies such as computer vision, biochemical reagents, and consumer electronics to accelerate the drug discovery process. Bioelectronica's flagship product, the Hypercell technology platform, offers high throughput digital biochemistry capabilities that enable quick and cost-effective analysis and sorting of cells, particularly secretors. This platform has been recognized for its innovation, notably being selected by the Society for Laboratory Automation and Screening as the most innovative new product in January 2020. Bioelectronica operates on a contract basis, providing cell sorting and analysis services to laboratories and research institutions. The company generates revenue through service contracts and sales of its proprietary technology. Bioelectronica serves clients in the life sciences sector, including pharmaceutical companies, academic institutions, and research labs, aiming to enhance their research capabilities and accelerate scientific discoveries. Keywords: digital biochemistry, cell sorting, drug discovery, computer vision, biochemical reagents, high throughput, life sciences, research-stage, biotechnology, Hypercell.
Company overview
Bioelectronica company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2017
- Headquarters
- Reno, United States
- Employees
- 15
- Open positions
- None listed
- Dealroom signal
- 41.1
Valuation & funding
Bioelectronica funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | Feb 2021 | $16M | $64M | Cowin Venture · Proxima Ventures | — |
| SEEDEquity / VC | May 2019 | $0 | — | Undisclosed | — |
Financials
Workforce over time
Available workforce history. Financial fields without reported data are omitted.
| Year | Employees |
|---|---|
| 2026 | 15 |
| 2025 | 16 |
| 2024 | 7 |
| 2023 | 13 |
| 2022 | 11 |
| 2021 | 19 |
Growth signals
Bioelectronica website traffic
Latest recorded traffic for Bioelectronica is 1.7K monthly website visits, up 95.4% over the last three months. Bioelectronica's team declined 6.3% over the past year.
Comparisons
Bioelectronica compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
Bioelectronica's talent
Source: Dealroom Talent Intelligence.
Investors
2 investors on Bioelectronica's cap table
Sourced from Dealroom's funding and investor records.
Global footprint
Where Bioelectronica has talent and traffic
team presence
In the news
Latest news about Bioelectronica
Recent press, funding announcements, and product moves mentioning Bioelectronica — open to read from the original sources.
Market sentiment
What the market is saying about Bioelectronica
An AI-synthesized read of the highest-engagement posts about Bioelectronica on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Bioelectronica’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.